From 1 October 2020 the following changes will be made to the National Immunisation Schedule.
From 1 July 2020 vaccine brand changes will take effect and the 3 month dose for Pneumococcal (Synflorix) will no longer be required. The schedule of vaccines listed below applies from 1 October 2020.
Links in the table above provide more information about the diseases and the vaccines that prevent them.
There will be brand changes for the varicella vaccine and Hepatitis B vaccines, and Tdap will replace ADT vaccine. These changes do not result in any changes to the scheduled timing of administration.
From 1 July to 30 September 2020 practices will continue to be supplied with the current vaccine brands until these vaccine stocks are depleted. As current brand stocks are used orders will be filled with the new stock brands. From 1 October 2020 providers will only be supplied with the new vaccine brands.
Funded vaccines for high risk groups
Publicly funded hepatitis A, hepatitis B, haemophilus influenzae type b, human papillomavirus, influenza, meningococcal ACWY, pertussis (Tdap), pneumococcal, tuberculosis and varicella vaccines are available for children and adults at high risk of some diseases due to other medical conditions. For more details see the Additional Funded vaccines for special groups page of the Immunisation Handbook.
As part of the schedule change, meningococcal C will only be available for high risk children less than 9 months, with those 9 months and older eligible for meningococcal ACWY.
Immunisation programme decisions
For information about how New Zealand's National Immunisation Schedule is determined and administered, see immunisation programme decisions.